View article

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

Authors

Fenici P Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen M, Thuresson M, Arya N, Bodegård J, Hammar N, CVD-REAL Investigators and Study Group

Publication date

2017/5/17

Journal

Circulation

Volume

136

Issue

Pages

249-259

Publisher

Circulation

Total citations

Cited by 855

2017201820192020202120222023202437 186 170 130 129 93 60 29

Scholar articles

Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors)*

M Kosiborod, MA Cavender, AZ Fu, JP Wilding… - Circulation, 2017

Lower risk of heart failure and death in patients initiated on SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study

M Kosiborod, MA Cavender, AZ Fu, JP Wilding… - Circulation, 2017

Cited by 122 Related articles